Medicine
Oncology

Prostate cancer
Classification


Home > Disciplines > Medicine > Oncology > Prostate cancer > Classification



CONTENTS



OVERVIEW


DUCTAL ADENOCARCINOMA


OLIGOMETASTATIC PROSTATE CANCER


RISK GROUPS


INTERMEDIATE-RISK GROUP


FAVORABLE INTERMEDIATE-RISK PROSTATE CANCER


SKENE’S GLAND ADENOCARCINOMA



OVERVIEW


.

Inamura K.
Prostatic cancers: understanding their molecular pathology and the 2016 WHO classification.
Oncotarget. 2018 Feb 16;9(18):14723-14737. doi: 10.18632/oncotarget.24515. eCollection 2018 Mar 6.
Source | Full text | Similar articles



.*

Kamoun A, Cancel-Tassin G, Fromont G, Elarouci N, Armenoult L, Ayadi M, Irani J, Leroy X, Villers A, Fournier G, Doucet L, Boyault S, Brureau L, Multigner L, Diedhiou A, Roupret M, Compérat E, Blanchet P, de Reyniès A, Cussenot O.
Comprehensive molecular classification of localized prostate adenocarcinoma reveals a tumour subtype predictive of a non-aggressive disease.
Ann Oncol. 2018 Jun 26. doi: 10.1093/annonc/mdy224. [Epub ahead of print]
Source | Full text | Similar articles



.*

Paner GP, Gandhi J, Choy B, Amin MB.
Essential Updates in Grading, Morphotyping, Reporting, and Staging of Prostate Carcinoma for General Surgical Pathologists.
Arch Pathol Lab Med. 2019 Mar 13. doi: 10.5858/arpa.2018-0334-RA. [Epub ahead of print]
Source | Full text | Similar articles



DUCTAL ADENOCARCINOMA


.

Dube VE, Farrow GM, Greene LF.
Prostatic adenocarcinoma of ductal origin.
Cancer. 1973 Aug;32(2):402-9.
Source | Full text | Similar articles



.

Greene LF, Farrow GM, Ravits JM, Tomera FM.
Prostatic adenocarcinoma of ductal origin.
J Urol. 1979 Mar;121(3):303-5.
Source | Full text | Similar articles



.

Gulavita P, Hakim SW, Schieda N, Breau RH, Morash C, Keefe DT, Robertson SJ, Mai KT, Belanger EC, Flood TA.
Prostatic ductal adenocarcinoma: An aggressive variant that is underdiagnosed and undersampled on transrectal ultrasound (TRUS)-guided needle biopsy.
Can Urol Assoc J. 2015 Sep-Oct;9(9-10):302-6. doi: 10.5489/cuaj.2976.
Source | Full text | Similar articles



.

Humphrey PA.
Intraductal Carcinoma of the Prostate.
J Urol. 2015 Nov;194(5):1434-5. doi: 10.1016/j.juro.2015.08.068. Epub 2015 Aug 17.
Source | Full text | Similar articles



.

Porter LH, Lawrence MG, Ilic D, Clouston D, Bolton DM, Frydenberg M, Murphy DG, Pezaro C, Risbridger GP, Taylor RA.
Systematic Review Links the Prevalence of Intraductal Carcinoma of the Prostate to Prostate Cancer Risk Categories.
Eur Urol. 2017 Oct;72(4):492-495. doi: 10.1016/j.eururo.2017.03.013. Epub 2017 Mar 22.
Source | Full text | Similar articles



.

Rhamy RK, Buchanan RD, Spalding MJ.
Intraductal carcinoma of the prostate gland.
J Urol. 1973 Mar;109(3):457-60.
Source | Full text | Similar articles



.

Taneja SS.
Re: Systematic Review Links the Prevalence of Intraductal Carcinoma of the Prostate to Prostate Cancer Risk Categories.
J Urol. 2017 Dec;198(6):1208-1211. doi: 10.1016/j.juro.2017.09.063. Epub 2017 Sep 15.
Source | Full text | Similar articles



OLIGOMETASTATIC PROSTATE CANCER


.

Weber E.
PCa Commentary – Vol #92.2 OLIGOMETASTATIC PROSTATE CANCER: What Is It? A Potential Option for Limited Therapy?
Prostate Cancer Treat Res Found, March-April 2015
Source | Full text



RISK GROUPS




INTERMEDIATE-RISK GROUP




Favorable intermediate-risk prostate cancer


.

Zumsteg ZS, Spratt DE, Pei I, Zhang Z, Yamada Y, Kollmeier M, Zelefsky MJ.
A new risk classification system for therapeutic decision making with intermediate-risk prostate cancer patients undergoing dose-escalated external-beam radiation therapy.
Eur Urol. 2013 Dec;64(6):895-902. doi: 10.1016/j.eururo.2013.03.033. Epub 2013 Mar 23.
Source | Full text | Similar articles



.

D'Amico AV.
Personalizing the management of men with intermediate-risk prostate cancer.
Eur Urol. 2013 Dec;64(6):903-4. doi: 10.1016/j.eururo.2013.03.038. Epub 2013 Mar 26.
Comment on: Zumsteg ZS et al, A new risk classification system for therapeutic decision making with intermediate-risk prostate cancer patients undergoing dose-escalated external-beam radiation therapy. Eur Urol. Epub 2013 Mar 23.
Source | Full text | Similar articles



.

Buyyounouski MK.
Prostate cancer: stratifying intermediate-risk patients for radiotherapy.
Nat Rev Urol. 2013 Aug;10(8):438-9. doi: 10.1038/nrurol.2013.142. Epub 2013 Jun 25.
Comment on: Zumsteg ZS et al, A new risk classification system for therapeutic decision making with intermediate-risk prostate cancer patients undergoing dose-escalated external-beam radiation therapy. Eur Urol. Epub 2013 Mar 23.
Source | Full text | Similar articles



SKENE’S GLAND ADENOCARCINOMA


.

Thum S, Haben B, Christ G, Sen Gupta R.
[Female prostate cancer?]
Pathologe. 2017 Jul 20. doi: 10.1007/s00292-017-0322-9. [Epub ahead of print] German.
Source | Full text | Similar articles